Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Vet Med Sci ; 79(11): 1861-1869, 2017 Nov 17.
Artículo en Inglés | MEDLINE | ID: mdl-28943597

RESUMEN

Klotho protein is recognized as having a renoprotective effect and is used as a biomarker for kidney injury. We investigated the level of Klotho protein in hyperoxaluria-induced kidney injury and the effects of vitamin E (Vit E) and vitamin C (Vit C) supplementation. Hyperoxaluria was induced by feeding 2% (w/v) Hydroxy-L-proline (HLP) in the drinking water for 21 days. Rats were divided into 5 groups; control (Group 1, n=7), HLP treated rats that received nothing else (Group 2, n=7), Vit E (Group 3, n=6), Vit C (Group 4, n=6) and both Vit E and Vit C (Group 5, n=7). Vit E (200 mg/kg) was injected on days 1, 6, 11 and 16, while Vit C (500 mg/kg) was given intravenously on days 1 and 11. The Klotho protein levels and oxidative status were measured. The expression level of kidney Klotho protein expression was significantly reduced by HLP-treatment, while the mRNA expression was higher (P<0.05), the plasma and kidney malondialdehyde and kidney superoxide dismutase activities were increased, and the kidney reduced glutathione and urinary total antioxidant status were decreased (P<0.05). All of these changes were ameliorated by administration of Vit E, Vit C or especially the co-administration of both. In conclusion, HLP-induced hyperoxaluria reduced the kidney Klotho protein level, which could be restored by Vit E and/or Vit C.


Asunto(s)
Glucuronidasa/metabolismo , Hiperoxaluria/tratamiento farmacológico , Riñón/efectos de los fármacos , Animales , Antioxidantes/administración & dosificación , Antioxidantes/análisis , Ácido Ascórbico/administración & dosificación , Glutatión/análisis , Hiperoxaluria/patología , Riñón/patología , Proteínas Klotho , Masculino , Malondialdehído/análisis , Modelos Animales , ARN Mensajero/metabolismo , Ratas Sprague-Dawley , Superóxido Dismutasa , Vitamina E/administración & dosificación
2.
J Vet Med Sci ; 79(5): 896-903, 2017 May 18.
Artículo en Inglés | MEDLINE | ID: mdl-28392511

RESUMEN

Hyperoxaluria and oxidative stress are risk factors in calcium oxalate (CaOx) stone formation. Supplement with antioxidant could be effective in prevention of recurrent stone formation. The present study aims to evaluate the protective effects of vitamin E and vitamin C in hyperoxaluric rat. The experiment was performed in rats for 21 days. Rats were divided into 5 groups as follows: control (group 1, n=8), hyperoxaluric rats (group 2, n=8), hyperoxaluric rats with vitamin E supplement (group 3, n=7), hyperoxaluric rats with vitamin C supplement (group 4, n=7) and hyperoxaluric rats with vitamin E and C supplement (group 5, n=7). Hyperoxaluria was induced by feeding hydroxyl L-proline (HLP) 2% w/v dissolved in drinking water. Intraperitoneal 200 mg/kg of vitamin E was given in groups 3 and 5 on days 1, 6, 11 and 16, while 500 mg of vitamin C was injected intravenously in groups 4 and 5 on days 1 and 11. Renal functions and oxidative status were measured. The urinary oxalate excretion was increased in HLP supplement rats, while glomerular filtration rate, proximal water and sodium reabsorption were significantly lower in group 2 compared with a control (P<0.05). Giving antioxidants significantly lower urinary calcium oxalate crystals (P<0.05). Hyperoxaluric rats had higher plasma malondialdehyde (PMDA) and lower urinary total antioxidant status (UTAS), which were alleviated by vitamin E and/or vitamin C supplement. In conclusion, giving combination of vitamin E and vitamin C exerts a protective role against HLP-induced oxalate nephropathy.


Asunto(s)
Antioxidantes/uso terapéutico , Ácido Ascórbico/uso terapéutico , Hiperoxaluria/tratamiento farmacológico , Riñón/efectos de los fármacos , Vitamina E/uso terapéutico , Animales , Antioxidantes/administración & dosificación , Ácido Ascórbico/administración & dosificación , Peso Corporal , Citratos/orina , Ingestión de Líquidos , Quimioterapia Combinada , Ingestión de Alimentos , Electrólitos/metabolismo , Hemodinámica , Hiperoxaluria/patología , Riñón/patología , Cálculos Renales/prevención & control , Glomérulos Renales/efectos de los fármacos , Glomérulos Renales/fisiología , Masculino , Oxalatos/orina , Sustancias Protectoras/uso terapéutico , Ratas , Ratas Sprague-Dawley , Vitamina E/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA